119 related articles for article (PubMed ID: 36068116)
1. Incidence of Brain Metastases in Women Treated With Neoadjuvant Chemotherapy for Breast Cancer: Implications for Screening.
Kozak MM; Karl J; von Eyben R; Guo F; Gutkin P; Horst K
Clin Breast Cancer; 2022 Dec; 22(8):e916-e921. PubMed ID: 36068116
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy.
Kozak MM; Jacobson CE; von Eyben R; Walck E; Pollom EL; Telli M; Horst KC
Clin Breast Cancer; 2018 Oct; 18(5):e1077-e1085. PubMed ID: 29843987
[TBL] [Abstract][Full Text] [Related]
3. Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients.
Canavese G; Tinterri C; Carli F; Garrone E; Spinaci S; Della Valle A; Barbieri E; Marrazzo E; Bruzzi P; Dozin B
Eur J Surg Oncol; 2021 Aug; 47(8):1920-1927. PubMed ID: 33972144
[TBL] [Abstract][Full Text] [Related]
4. Outcomes Following Neoadjuvant Chemotherapy for Breast Cancer in Women Aged 40 Years and Younger: Impact of Pathologic Nodal Response.
Kozak MM; Jacobson CE; von Eyben R; Pollom EL; Telli M; Horst KC
J Natl Compr Canc Netw; 2018 Jul; 16(7):845-850. PubMed ID: 30006427
[No Abstract] [Full Text] [Related]
5. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
6. Development and external validation of a prediction model for brain metastases in patients with metastatic breast cancer.
Wu Q; Sun MS; Liu YH; Ye JM; Xu L
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12333-12353. PubMed ID: 37432458
[TBL] [Abstract][Full Text] [Related]
7. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
Jin J; Gao Y; Zhang J; Wang L; Wang B; Cao J; Shao Z; Wang Z
BMC Cancer; 2018 Apr; 18(1):446. PubMed ID: 29673325
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.
Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK
Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386
[TBL] [Abstract][Full Text] [Related]
9. Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience.
Hughes RT; Masters AH; McTyre ER; Farris MK; Chung C; Page BR; Kleinberg LR; Hepel J; Contessa JN; Chiang V; Ruiz J; Watabe K; Su J; Fiveash JB; Braunstein S; Chao S; Attia A; Ayala-Peacock DN; Chan MD
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1091-1098. PubMed ID: 30959122
[TBL] [Abstract][Full Text] [Related]
10. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
11. Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy.
Buchholz TA; Hill BS; Tucker SL; Frye DK; Kuerer HM; Buzdar AU; McNeese MD; Singletary SE; Ueno NT; Pusztai L; Valero V; Hortobagyi GN
Cancer J; 2001; 7(5):413-20. PubMed ID: 11693900
[TBL] [Abstract][Full Text] [Related]
12. Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based model.
Gabani P; Weiner AA; Hernandez-Aya LF; Khwaja S; Roach MC; Ochoa LL; Mullen D; Thomas MA; Matesa MA; Margenthaler JA; Cyr AE; Naughton MJ; Ma C; Sanati S; Zoberi I
Breast J; 2019 May; 25(3):363-372. PubMed ID: 30920124
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.
Wong SM; Almana N; Choi J; Hu J; Gagnon H; Natsuhara K; Shen AH; DeSantis S; Dominici L; Golshan M; Weiss A; Bellon J; Mittendorf EA; King TA
Ann Surg Oncol; 2019 Oct; 26(11):3502-3509. PubMed ID: 31228134
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy.
Asaoka M; Narui K; Suganuma N; Chishima T; Yamada A; Sugae S; Kawai S; Uenaka N; Teraoka S; Miyahara K; Kawate T; Sato E; Nagao T; Matsubara Y; Gandhi S; Takabe K; Ishikawa T
Eur J Surg Oncol; 2019 Dec; 45(12):2289-2294. PubMed ID: 31787153
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation.
Keilty D; Nezafat Namini S; Swain M; Maganti M; Cil TD; McCready DR; Cescon DW; Amir E; Fleming R; Mulligan AM; Fyles A; Croke JM; Liu FF; Levin W; Koch CA; Han K
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):676-685. PubMed ID: 32407932
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
[TBL] [Abstract][Full Text] [Related]
17. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
[TBL] [Abstract][Full Text] [Related]
18. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.
Beek MA; Tetteroo E; Luiten EJ; Gobardhan PD; Rutten HJ; Heijns JB; Voogd AC; Klompenhouwer EG
Eur J Surg Oncol; 2016 May; 42(5):672-8. PubMed ID: 26898838
[TBL] [Abstract][Full Text] [Related]
20. Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer.
Sinukumar S; Damodaran D; Ray M; Mehta S; Paul L; Bhatt A
Eur J Surg Oncol; 2021 Jun; 47(6):1427-1433. PubMed ID: 33509612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]